Entrada Therapeutics, Inc. (TRDA)

Last Year

23-Nov-23 -- 22-Nov-24

Time Period:

$25.68K Net Amount

Buy:	$25.68K	$12.66 - $12.66
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

10

0

5

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
10-Sep-24 4:34 PM View:	09-Sep-24 Private Sale (Planned) ($47.83K)	Wentworth Kory James Chief Financial Officer		Entrada Therapeutics, Inc. - TRDA	54% 49.57K to 76.49K	0	0	--	--	Show Txns Hide Txns

10-Sep-24 4:32 PM View:	09-Sep-24 Sale (Planned) ($39.86K)	Sethuraman Natarajan Chief Scientific Officer		Entrada Therapeutics, Inc. - TRDA	10% 167.2K to 183.82K	0	0	--	--	Show Txns Hide Txns

05-Jun-24 4:31 PM View:	03-Jun-24 Option Exercise $72.22K	Kim Peter S Director		Entrada Therapeutics, Inc. - TRDA	122% 47.04K to 104.33K	$25.68K 4%	0	$12.66 - $12.66	--	Show Txns Hide Txns

05-Sep-24 6:49 PM View:	05-Sep-24 Payment of Exercise ($12.49K)	Doshi Dipal CEO Director		Entrada Therapeutics, Inc. - TRDA	32% 246.28K to 325.75K	0	0	--	--	Show Txns Hide Txns

30-Sep-24 4:32 PM View:	26-Sep-24 Private Sale (Planned) ($13.55K)	Dowden Nathan J President & COO		Entrada Therapeutics, Inc. - TRDA	160% 48.17K to 125.15K	0	0	--	--	Show Txns Hide Txns